🔎 Trials Near Me

Pradžia › 2 tipo cukrinis diabetas › Konektikutas

2 tipo cukrinis diabetas klinikiniai tyrimai Konektikutas

14 tyrimai dėl 2 tipo cukrinis diabetas ieško dalyvių vietose Konektikutas.

Miestai Konektikutas

Oficialus tyrimo tekstas (anglų kalba)

Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema

  • Chase Medical Research LLC, Waterbury
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07817251

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

  • Cardiology Physicians of Fairfield County - Bridgeport, Bridgeport
  • CMR of Greater New Haven, LLC, Hamden
  • Cardiology Associates of Fairfield County, Stamford
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-30 · NCT07064473

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • New England Research Associates, LLC, Bridgeport
  • CMR of Greater New Haven, LLC, Hamden
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-22 · NCT07282600

Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease

  • Yale University, New Haven
Renkami dalyviai2 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-11 · NCT07271186

A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus

  • Research Site, Bridgeport
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07662213

A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes

  • Yale School of Medicine, New Haven
Renkami dalyviai3 fazė
Amžius nuo 10 iki 18 · Visoms lytims · Atnaujinta 2026-09-09 · NCT07282613

A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus

  • Research Site, Bridgeport
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-31 · NCT07662044

A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)

  • Yale Diabetes Research, New Haven
Renkami dalyviai3 fazė
Amžius nuo 10 iki 17 · Visoms lytims · Atnaujinta 2026-08-07 · NCT06739122

Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  • Yale, New Haven
Renkami dalyviai
Amžius nuo 14 iki 75 · Visoms lytims · Atnaujinta 2026-08-03 · NCT07579702

Effect of the Thrive AI Health App on Lifestyle Behaviors and Quality of Life

  • Yale University, New Haven
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-06-17 · NCT07376655

Ultrasound Effects on Glycemic Control in T2DM

  • Yale-New Haven Hospital, New Haven
Renkami dalyviai
Amžius nuo 21 iki 75 · Visoms lytims · Atnaujinta 2026-01-27 · NCT05354947

Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

  • Fair Haven Community Health Care (FHCHC), New Haven
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-12-03 · NCT06658067

Diabetes Learning in Virtual Environments Just in Time for Community Reentry

  • University of Connecticut, Storrs
  • University of Connecticut, Storrs Mansfield
Renkami dalyviai
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2025-07-28 · NCT05286892

Reversibility of Brain Glucose Transport in Type 2 Diabetes Mellitus (T2DM)

  • Yale New Haven Hospital (YNHH) Research Unit (HRU), New Haven
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2025-01-14 · NCT05776563

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.